Report overview
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a "catch-all" for all non-LVP parenterals products except biologicals.
This report aims to provide a comprehensive presentation of the global market for Parenteral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Drugs. This report contains market size and forecasts of Parenteral Drugs in global, including the following market information:
Global Parenteral Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Parenteral Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Parenteral Drugs companies in 2022 (%)
The global Parenteral Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail.
We surveyed the Parenteral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parenteral Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Type, 2022 (%)
LVP Drug
SVP Drug
Global Parenteral Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Medical Centers
Others
Global Parenteral Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parenteral Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Parenteral Drugs revenues share in global market, 2022 (%)
Key companies Parenteral Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Parenteral Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Parenteral Drugs, market overview.
Chapter 2: Global Parenteral Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parenteral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Parenteral Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
